Progressive epilepsy-intellectual disability syndrome, Finnish type (PEID-FT) is a rare genetic disorder characterized by progressive intellectual disability, seizures, and other neurological problems. It is caused by a mutation in the SLC25A22 gene and is only found in Finland. Symptoms typically begin in early childhood and include intellectual disability, seizures, poor coordination, and behavioral problems. Treatment is symptomatic and may include anticonvulsant medications, physical and occupational therapy, and speech therapy.

The symptoms of Progressive epilepsy-Intellectual disability syndrome, Finnish type, include:

-Seizures that begin in infancy or early childhood
-Developmental delay
-Intellectual disability
-Speech and language delays
-Motor delays
-Behavioral problems
-Growth delays
-Facial dysmorphism
-Abnormal EEG findings
-Cognitive impairment
-Impaired social interaction
-Impaired communication
-Impaired motor skills
-Impaired coordination
-Impaired balance
-Impaired vision
-Impaired hearing
-Impaired memory
-Impaired judgment
-Impaired problem-solving skills
-Impaired executive functioning
-Impaired attention
-Impaired abstract thinking
-Impaired learning
-Impaired social skills
-Impaired self-care skills
-Imp

The cause of Progressive epilepsy-intellectual disability syndrome, Finnish type is unknown. It is believed to be caused by a genetic mutation, but the exact gene responsible has not yet been identified. It is thought to be inherited in an autosomal recessive pattern, meaning that both parents must carry the mutated gene in order for their child to be affected.

The treatments for Progressive epilepsy-intellectual disability syndrome, Finnish type, are largely supportive and symptomatic. Treatment focuses on controlling seizures, managing behavioral issues, and providing supportive care. Medications such as anticonvulsants, antipsychotics, and antidepressants may be used to control seizures and manage behavioral issues. Physical, occupational, and speech therapy may be used to help improve motor skills, communication, and daily living activities. Nutritional and dietary interventions may also be used to help manage symptoms. In some cases, surgery may be recommended to reduce the severity of seizures.

1. Genetic mutation: Progressive epilepsy-intellectual disability syndrome, Finnish type is caused by a mutation in the EFHC1 gene.

2. Family history: Having a family history of Progressive epilepsy-intellectual disability syndrome, Finnish type increases the risk of developing the condition.

3. Gender: The condition is more common in males than females.

4. Age: The condition is more common in children and young adults.

At this time, there is no known cure for Progressive Epilepsy-Intellectual Disability Syndrome, Finnish Type. However, medications can be used to help manage the symptoms of the condition. These medications may include anticonvulsants, anti-epileptic drugs, and other medications to help control seizures, reduce anxiety, and improve behavior. Additionally, physical and occupational therapy, speech therapy, and other supportive therapies may be beneficial in helping individuals with this condition to reach their full potential.